Smith & Nephew plc (BVMF:S1NN34)

Market Cap	71.85B -4.5%
Revenue (ttm)	33.95B +6.1%
Net Income	3.44B +51.7%
EPS	3.94 +52.3%
Shares Out	n/a
PE Ratio	20.87
Forward PE	14.29
Dividend	0.78 (2.32%)
Ex-Dividend Date	Oct 2, 2025

Volume	n/a
Average Volume	77
Open	33.70
Previous Close	33.70
Day's Range	33.70 - 33.70
52-Week Range	31.92 - 40.88
Beta	0.68
RSI	45.73
Earnings Date	Mar 2, 2026

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction proced...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1856
• Employees: 17,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: S1NN34

Financial Performance

In 2025, Smith & Nephew's revenue was $6.16 billion, an increase of 6.09% compared to the previous year's $5.81 billion. Earnings were $625.00 million, an increase of 51.70%.

Financial numbers in USD